Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing AxSpA: Incidence of uveitis following bimekizumab treatment
24:11
24:11
Play later
Play later
Lists
Like
Liked
24:11
Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenofon Baraliakos to discuss a recent study on the incidence of uveitis in patients with axSpA that were treated with bimekizumab.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Author Interview: Professor Laura Andreoli, 2024
44:09
44:09
Play later
Play later
Lists
Like
Liked
44:09
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Laura Andreoli, a Professor of Rheumatology at the University of Brescia, as they discuss her recent paper ‘The outcomes of children born to mothers with autoimmune rheumatic diseases’, published in The Lancet. Rheumatology on 11th June 2024.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing RA: Neutrophil-to-lymphocyte ratio and treatment response to filgotinib
16:05
16:05
Play later
Play later
Lists
Like
Liked
16:05
Join Professor Iain McInnes and Professors Hideto Kameda and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss a paper that investigated whether the baseline neutrophil-to-lymphocyte ratio had an effect on the treatment respons…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing PsA: Guselkumab and analysis of genetic markers
25:46
25:46
Play later
Play later
Lists
Like
Liked
25:46
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation covered the post hoc analysis of PsA patients receiving guselkumab, focusing on disease control across domains and patient characteristics, and a systematic review and meta-analysis on genetic markers and…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing AxSpA: Upadacitinib in nr-axSpA and certolizumab pegol by baseline MRI and CRP status
22:14
22:14
Play later
Play later
Lists
Like
Liked
22:14
Join us for the latest axSpA podcast brought to you by the Immune- ediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda and Xenofon Baraliakos to discuss the results of a Phase 3 trial on upadacitinib in nr-axSpA and the clinical outcomes of certolizumab pegol treatment in nr-axSpA stratified by base…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing PsA: Bimekizumab therapy in PsA
29:49
29:49
Play later
Play later
Lists
Like
Liked
29:49
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the latest publication by Su, et al. and discuss the latest in bimekizumab therapy in PsA.By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
![Artwork](/static/images/128pixel.png)
1
IMID Author Interview: Dr Blanca Hernández-Cruz, 2024
33:50
33:50
Play later
Play later
Lists
Like
Liked
33:50
Join Professor Peter Nash from the Griffith University in Brisbane, and Blanca Hernández-Cruz, a rheumatologist at Virgen Macarena University Hospital in Seville, as they discuss her recent paper ‘Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing AxSpA: Long-term etanercept response & real-world effectiveness of tofacitinib & adalimumab
29:48
29:48
Play later
Play later
Lists
Like
Liked
29:48
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the long-term etanercept response in patients with radiographic axSpA and the comparison of tofacitinib and adalimumab in a real-worl…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing PsA: 2023 EULAR recommendations and improvements in PROs with deucravacitinib
28:33
28:33
Play later
Play later
Lists
Like
Liked
28:33
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, they focus on the updated 2023 EULAR recommendations for PsA and the improvement of PROs reported in a Phase 2 trial with deucravacitinib.By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing AxSpA: Secukinumab retention over time & sacroiliac joint improvements between DMARDs
33:01
33:01
Play later
Play later
Lists
Like
Liked
33:01
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Atul Deodhar to discuss the retention rate of secukinumab over two different time periods. Our faculty then move on to discuss another publication, which compares the improvement…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing PsA: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population
38:13
38:13
Play later
Play later
Lists
Like
Liked
38:13
Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the long-term safety of ixekizumab as well as bimekizumab treatment in a TNFi-IR population.By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology. In this episode, he discusses two papers that that add to the knowledge of common treatments relating to RA. In our first paper, Juergen Rech and colleagues present the results of …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing AxSpA: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment
32:38
32:38
Play later
Play later
Lists
Like
Liked
32:38
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar and Xenofon Baraliakos to discuss the risk of acute anterior uveitis across different bDMARDs in patients with AS. Our faculty then move on to discuss another publicati…
…
continue reading
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology. In this episode, he discusses two papers that show the long-term safety and efficacy of JAK inhibitors, both of which have a study period of 6.5 years. In our first paper, Roberto …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing PsA: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs
32:10
32:10
Play later
Play later
Lists
Like
Liked
32:10
Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, including the clinical response to guselkumab and the research surrounding sequential lines of b/tsDMARDs.By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Professor Iain McInnes for the first episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in rheumatology.In this episode, he discusses two papers that aimed to advise on treatment of rheumatic diseases in a real-world setting. In our first paper, Emma Dures and her colleagues compiled t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing AxSpA: Long-Term Outcomes of Secukinumab & JAKis in Clinical Practice
25:05
25:05
Play later
Play later
Lists
Like
Liked
25:05
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Xenofon Baraliakos to discuss the long-term impact of secukinumab treatment on bone-related outcomes and BTMs in r-AxSpA patients over two years. Our faculty then move on to disc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing PsA: Secukinumab & The Effect of Sex on the Long-Term Persistence of Targeted Therapies
30:33
30:33
Play later
Play later
Lists
Like
Liked
30:33
Join Professors Peter Nash, Philip Mease, Frank Behrens, and Laura Coates as they discuss the top publications in the world of PsA. They discuss two highly relevant topics in the field, namely the effect of sex on the long-term persistence of targeted therapies, as well as the impact of secukinumab on synovitis and enthesitis.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Discussing AxSpA: Bimekizumab in AxSpA & Secukinumab Patient Clustering
26:26
26:26
Play later
Play later
Lists
Like
Liked
26:26
Join us for the latest axSpA podcast brought to you by the CSF! This month Dr Sofia Ramiro, consultant rheumatologist and senior researcher at Leiden University Medical Centre and Zuyderland Medical Centre, is joined once again by experts with a wealth of clinical knowledge. Joining her is Hideto Kameda, Professor of Internal Medicine at Toho Unive…
…
continue reading
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Adam Goldman, an epidemiology researcher at The Chaim Sheba Medical Center in Tel-Hashomer, and an epidemiology researcher and lecturer at Tel-Aviv University, as they discuss his recent paper ‘Adverse cardiovascular events in rheumatoid arthritis patients treated with JAK i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Author Interview: Professor Daniel Blockmans, 2024
26:44
26:44
Play later
Play later
Lists
Like
Liked
26:44
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Daniel Blockmans, from the Department of Internal Medicine at the University Hospitals Leuven, as they discuss his recent paper ‘Efficacy and safety of upadacitinib in patients with giant cell arteritis (SELECT-GCA): A double-blind, randomized controlled Phase 3 trial…
…
continue reading
Join Professor Iain McInnes and guest Professor Maurizio Cutolo for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, two papers that cover important topics in rheumatology are highlighted: the first paper presents the 5-year efficacy and safety results o…
…
continue reading
Join Professors Iain McInnes, Peter Nash, and Maurizio Cutolo for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode they discuss two papers, one that investigated the long-term safety of filgotinib in moderate-to-severe RA, and the other a postmarketing an…
…
continue reading
Join Dr Sofia Ramiro, Professor Rieke Alten, and Associate Professor Laura Coates as they review their top sessions in RA, PsA, and axSpA from EULAR 2024, providing insight into how these data will shape clinical practice going forward.By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of EULAR 2024 (Saturday, June 15).By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 3 of EULAR 2024 (Friday, June 14).By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 2 of EULAR 2024 (Thursday, June 13).By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Dr Sofia Ramiro as she summarises her top abstracts, posters, and presentations from Day 1 of EULAR 2024 (Wednesday, June 12).By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Dr Sofia Ramiro, Professor Rieke Alten, and Associate Professor Laura Coates as they guide you through their top selections in RA, PsA, and axSpA at EULAR 2024, so that you can better plan your time at what will be a busy and exciting congress.By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Professor Iain McInnes and guests Professor Janet Pope and Dr Sofia Ramiro for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in RA. In this episode, he discusses two papers that investigated the long-term safety of JAK inhibitors from Phase 3 trials. In our first paper,…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
IMID Author Interview: Dorthe Berthelsen, 2024
23:26
23:26
Play later
Play later
Lists
Like
Liked
23:26
Join Professor Peter Nash from the Griffith University in Brisbane, and Dorthe Berthelsen, a PhD student and physiotherapist at the Parker Institute in Copenhagen and at the University of Southern Denmark, as they discuss her recent paper ‘“I couldn't carry on taking a drug like that”: A qualitative study of patient perspectives on side effects fro…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Webinar Highlights Podcast: Evolving Therapeutic Strategies for Psoriatic Diseases
29:42
29:42
Play later
Play later
Lists
Like
Liked
29:42
Webinar Highlights Podcast: Join Professor Iain McInnes and Associate Professor Laura Coates on the Immune-Mediated Inflammatory Disease Forum in their discussion on the recent webinar “Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar”. Watch them discuss key highlights from the webinar including the burden…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
IMID Author Interview: Dr Jake Weddell, 2024
21:01
21:01
Play later
Play later
Lists
Like
Liked
21:01
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Jake Weddell, an academic rheumatology trainee at Leeds Teaching Hospitals NHS Trust, as they discuss his recent paper ‘Real-world experience of IL-17Ai drug survival in a large cohort of axial spondyloarthritis and psoriatic arthritis.’…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
IMID Author Interview: Professor Frank Verhoeven, 2024
20:36
20:36
Play later
Play later
Lists
Like
Liked
20:36
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Frank Verhoeven, an Assistant Professor in Rheumatology at the CHU Besancon in France, as they discuss his recent paper ‘Effects of disease‑modifying anti‑rheumatic drugs on sacroiliac MRI score in axial spondyloarthritis: A systematic review and meta‑analysis.’…
…
continue reading
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest information and data in RA. In this episode, he discusses two papers related to the long-term safety of JAK inhibitors compared to TNF inhibitors. In our first paper, Christina Charles-Schoeman and colleagues assessed …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Author Interview: Professor Maria Antonietta D’Agostino, 2024
22:15
22:15
Play later
Play later
Lists
Like
Liked
22:15
Join Professor Peter Nash from the Griffith University in Brisbane, and Maria Antonietta D’Agostino, the Head of the Rheumatology Department at the Catholic University of the Sacred Heart in Rome, as they discuss her recent paper 'Effects of Secukinumab on Synovitis and Enthesitis in Patients with Psoriatic Arthritis: 52-week Clinical and Ultrasoun…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Author Interview: Professor Dennis McGonagle, 2024
31:18
31:18
Play later
Play later
Lists
Like
Liked
31:18
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Dennis McGonagle, a Clinical Professor at the University of Leeds School of Medicine, as they discuss his recent paper ‘Association of the Clinical Components in the Distal Interphalangeal Joint Synovio-entheseal Complex and Subsequent Response to Ixekizumab or Adalim…
…
continue reading
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Jürgen Rech, a Senior Physician at the Friedrich-Alexander University of Erlangen-Nürnberg, as they discuss his recent paper ‘Abatacept Inhibits Inflammation and Onset of Rheumatoid Arthritis in Individuals at High Risk (ARIAA): A Randomised, International, Multicentre, Doub…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Author Interview: Dr Mahta Mortezavi, 2024
20:18
20:18
Play later
Play later
Lists
Like
Liked
20:18
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Mahta Mortezavi, a Clinical Director for Drug Discovery and Early Development as part of the Anti-infectives Research Unit at Pfizer, as they discuss her recent paper ‘Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumour necros…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Author Interview: Professor Andrew Cope, Professor Paul Emery and Professor John Issacs
43:10
43:10
Play later
Play later
Lists
Like
Liked
43:10
Join Professor Peter Nash from the Griffith University in Brisbane, as well as Professors Andrew Cope, Professor of Rheumatology and Head of the Centre for Rheumatic Diseases at Kings College London, Professor Paul Emery, Clinical Professor and Director of the Leeds Biomedical Research Centre, and Professor John Isaacs, Professor of clinical immuno…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Author Interview: Dr Kehinde Sunmboye, 2024
18:05
18:05
Play later
Play later
Lists
Like
Liked
18:05
Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Kehinde Sunmboye, a consultant rheumatologist at the University Hospitals of Leicester NHS Trust, in this episode of the Author Interview series. Dr Sunmboye discusses his recent paper 'Cardiovascular safety of Janus Kinase inhibitor therapy in a multi-ethnic population' wit…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Author Interview: Professor Andrea Rubbert-Roth, 2023
25:17
25:17
Play later
Play later
Lists
Like
Liked
25:17
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrea Rubbert-Roth, a doctor of rheumatology and internal medicine at the Kantonsspital St Gallen in Switzerland, as they discuss her recent paper 'Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, a…
…
continue reading
Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology.In this episode, he discusses two papers that compare the efficacy and safety of JAK inhibitors as RA therapies. In our first paper, Shinya Hayashi and his colleagues carried out a retrospective study to compare the efficacy o…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PsA Podcast: Impact of Biological Sex on Advanced Therapies & Upadacitinib-related Malignancies
27:19
27:19
Play later
Play later
Lists
Like
Liked
27:19
Join Philip Mease, Professor at the University of Washington School of Medicine and Director of Rheumatology Research at the Swedish Medical Centre in Seattle, USA, and Laura Coates, an Associate Professor, NIHR clinician scientist and senior clinical research fellow at the Oxford Psoriatic Arthritis Centre, as they discuss two important topics fro…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab
33:10
33:10
Play later
Play later
Lists
Like
Liked
33:10
Join Doctor Sofia Ramiro as she is joined by Professors Atul Deodhar and Xenofon Baraliakos to discuss the latest top clinical research in the world of axSpA. In the first paper discussed, the authors evaluated the efficacy and safety of tofacitinib in bDMARD-naïve and TNF-IR AS patients. The second paper presents the results of two parallel clinic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA
21:09
21:09
Play later
Play later
Lists
Like
Liked
21:09
Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia, Philip Mease, Professor at the University of Washington School of Medicine, and Director of Rheumatology Research at the Swedish Medical Centre in Seattle, USA, as well as Laura Coates, an Assoc…
…
continue reading
Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology.In this episode, he discusses two papers that look at the incidence of disease. The first paper, the GBD 2021 Other Musculoskeletal Disorders Collaborators systematically analysed the global burden of musculoskeletal disorders…
…
continue reading
Join Sofia Ramiro as she goes through our top abstracts, posters, and presentations from Day 4 of ACR 2023 today (Wednesday 15 November).They're all available right here on the CSF YouTube channel, so make sure you don't miss them!By The Immune-Mediated Inflammatory Disease Forum
…
continue reading
Join Grace Wright as she goes through our top abstracts, posters, and presentations from Day 3 of ACR 2023 today (Tuesday 14 November).They're all available right here on the CSF YouTube channel, so make sure you don't miss them!By The Immune-Mediated Inflammatory Disease Forum
…
continue reading